Clinical Trial Update: CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating CD7-directed CAR T-cell therapy for relapsed/refractory T-cell lymphomas (including PTCL and CTCL) is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Peripheral T-cell Lymphoma
• T-cell Non-hodgkin Lymphoma

Drugs mentioned

• CD7 CAR-T cell therapy

Snippet

Sponsor: Beijing GoBroad Hospital | Conditions: T-Cell Non-Hodgkin Lymphoma, T-cell Lymphoma (PTCL and CTCL) | Phase 1, Phase 2 | Status: RECRUITING